These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 15855281)
1. CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16). Helbling D; Mueller BU; Timchenko NA; Schardt J; Eyer M; Betts DR; Jotterand M; Meyer-Monard S; Fey MF; Pabst T Blood; 2005 Aug; 106(4):1369-75. PubMed ID: 15855281 [TBL] [Abstract][Full Text] [Related]
2. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias. Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670 [TBL] [Abstract][Full Text] [Related]
3. The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Helbling D; Mueller BU; Timchenko NA; Hagemeijer A; Jotterand M; Meyer-Monard S; Lister A; Rowley JD; Huegli B; Fey MF; Pabst T Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13312-7. PubMed ID: 15326310 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22). Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086 [TBL] [Abstract][Full Text] [Related]
5. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission. Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11. Shigesada K; van de Sluis B; Liu PP Oncogene; 2004 May; 23(24):4297-307. PubMed ID: 15156186 [TBL] [Abstract][Full Text] [Related]
7. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells. Miller JD; Stacy T; Liu PP; Speck NA Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585 [TBL] [Abstract][Full Text] [Related]
9. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia. Castilla LH; Bushweller JH Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661 [TBL] [Abstract][Full Text] [Related]
10. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients. Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753 [TBL] [Abstract][Full Text] [Related]
11. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? Dissing M; Le Beau MM; Pedersen-Bjergaard J J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906 [TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Hébert J; Cayuela JM; Daniel MT; Berger R; Sigaux F Blood; 1994 Oct; 84(7):2291-6. PubMed ID: 7919348 [TBL] [Abstract][Full Text] [Related]
14. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development. Zhen T; Cao Y; Ren G; Zhao L; Hyde RK; Lopez G; Feng D; Alemu L; Zhao K; Liu PP Blood; 2020 Nov; 136(21):2373-2385. PubMed ID: 32929473 [TBL] [Abstract][Full Text] [Related]
15. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041 [TBL] [Abstract][Full Text] [Related]
16. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients. Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858 [TBL] [Abstract][Full Text] [Related]
17. HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia. Richter LE; Wang Y; Becker ME; Coburn RA; Williams JT; Amador C; Hyde RK Mol Cancer Res; 2019 Jun; 17(6):1241-1252. PubMed ID: 30814129 [TBL] [Abstract][Full Text] [Related]
18. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study. Rogers HJ; Hsi ED; Tang G; Wang SA; Bueso-Ramos CE; Lubin D; Morrissette JJ; Bagg A; Cherukuri DP; George TI; Peterson L; Liu YC; Mathew S; Orazi A; Hasserjian RP Am J Clin Pathol; 2017 Apr; 147(4):411-419. PubMed ID: 28375434 [TBL] [Abstract][Full Text] [Related]
19. Activation of the unfolded protein response in human acute myeloid leukemia. Schardt JA; Mueller BU; Pabst T Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233 [TBL] [Abstract][Full Text] [Related]
20. Function of the inv(16) fusion gene CBFB-MYH11. Kundu M; Liu PP Curr Opin Hematol; 2001 Jul; 8(4):201-5. PubMed ID: 11561156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]